Atlas Trials

Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a

Clinical trial NCT02218736 · COMPLETED

Trial details

NCT number
NCT02218736
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)
Start date
2015-06-01
Primary completion
2017-11-01
Enrollment
163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.